Get the Stockscreener App
2.05
1.91%
-0.04
Ensysce Biosciences Inc stock is traded at $2.05, with a volume of 432.60K.
It is down -1.91% in the last 24 hours and down -8.48% over the past month.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
See More
Previous Close:
$2.09
Open:
$2.06
24h Volume:
432.60K
Relative Volume:
1.01
Market Cap:
$4.86M
Revenue:
-
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.6811
EPS:
-3.01
Net Cash Flow:
$-9.78M
1W Performance:
-8.48%
1M Performance:
-8.48%
6M Performance:
-70.17%
1Y Performance:
-70.45%
1-Day Range:
$1.9797
$2.175
1-Week Range:
$1.95
$2.3699
52-Week Range:
$1.62
$14.67
Ensysce Biosciences Inc Stock (ENSC) Company Profile
Name
Ensysce Biosciences Inc
Sector
Industry
Phone
(858) 263-4196
Address
7946 IVANHOE AVENUE, LA JOLLA
Compare ENSC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENSC
Ensysce Biosciences Inc
|
2.05 | 4.95M | 0 | -11.28M | -9.78M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Ensysce Biosciences Inc Stock (ENSC) Latest News
Best data tools to analyze Ensysce Biosciences Inc. stockReal Stock Picks With Setup Verification - Newser
What Fibonacci levels say about Ensysce Biosciences Inc. reboundDaily Profit Watch With Forecast Confidence - Newser
What technical models suggest about Ensysce Biosciences Inc.’s comebackTrading Volume Anomaly Summary and Insight - Newser
When is Ensysce Biosciences Inc. stock expected to show significant growthBreakout Stocks Picks That Work - jammulinksnews.com
Is Ensysce Biosciences Inc. stock poised for growthFree Access to Real-Time Trade Insights - Newser
How to recover losses in Ensysce Biosciences Inc. stockSwing Trade Entry and Exit Point Analysis - Newser
Key resistance and support levels for Ensysce Biosciences Inc.Free Alpha Focused Technical Trade Signals - Newser
How to manage a losing position in Ensysce Biosciences Inc.Free Fast Entry High Potential Stock Alerts - Newser
Will Ensysce Biosciences Inc. rebound enough to break evenTechnical Chart Summary for Momentum Stocks - Newser
Volatility clustering patterns for Ensysce Biosciences Inc.Free Target Return Focused Trade Insights - Newser
Why Ensysce Biosciences Inc. stock attracts strong analyst attentionEarnings Based Stock Performance Forecast - Newser
Does Ensysce Biosciences Inc. stock perform well during market downturnsSwing Trade Outlook For Every Investor - jammulinksnews.com
What institutional investors are buying Ensysce Biosciences Inc. stockWealth Building Target Finder To Watch Now - jammulinksnews.com
First-Ever Smart Opioid With Automatic Overdose Protection Gets FDA Green Light for Development - Stock Titan
Should I hold or sell Ensysce Biosciences Inc. stock in 2025Pre Market Target Finder For 2025 - jammulinksnews.com
What makes Ensysce Biosciences Inc. stock price move sharplyLoss Limitation Strategy Based on Analysis - Newser
Chart Patterns Forming a Bullish Setup in Ensysce Biosciences Inc.Entry Plan for Oversold Reversal Stocks Released - metal.it
Buy Signal for Ensysce Biosciences Inc. Stock Key Technical Indicators to WatchReal Time Stock Movement and Alerts - Newser
How many analysts rate Ensysce Biosciences Inc. as a “Buy”Discover high-impact stocks for your portfolio - jammulinksnews.com
How strong is Ensysce Biosciences Inc. company’s balance sheetExceptional stock performance - jammulinksnews.com
How volatile is Ensysce Biosciences Inc. stock compared to the marketStay ahead with advanced stock screening tools - jammulinksnews.com
Why is Ensysce Biosciences Inc. stock attracting strong analyst attentionBuild a diversified portfolio for risk management - jammulinksnews.com
Has Ensysce Biosciences Inc. Stock Ever Crashed Historical Volatility ReviewTop Performing Stocks - Newser
Is Ensysce Biosciences Inc. a good long term investmentHigh-yield investments - PrintWeekIndia
What drives Ensysce Biosciences Inc. stock priceExponential wealth increase - Autocar Professional
Published on: 2025-07-25 08:23:29 - PrintWeekIndia
Ensysce Biosciences Inc Stock (ENSC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):